SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A sharp price-and-volume move alongside unusually heavy upside-call trading has fueled speculation about a leak or short covering ahead of the awaited REGAL Phase 3 GPS update in AML. Some traders also expect a buyout, but others stress that no company catalyst is confirmed and the trial outcome remains uncertain.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digitals proposed convertible-note offering is driving the sharp selloff, with traders concerned about potential dilution, share-hedging pressure and the timing of the financing. Others view the zero-interest funding as support for its AI data-center expansion and are buying the dip, leaving the discussion split between near-term dilution concerns and the longer-term growth case.

W.F Holding Ltd. engages in the manufacture of fiberglass reinforced plastic and FRP products. It sells a range of FRP products, including filament wound and molded tanks, thermoplastic tanks, lining products, ducting and fitting products, air pollution control equipment, and custom-made products. The firm also offer delivery, installation and repair, maintenance services, and on-site consultation services. The company was founded on March 7, 2023 and is headquartered in Shah Alam, Malaysia.

WF Holding Ltd.

WF Holding Limited Ordinary Shares

WFF is drawing attention after an extreme low-float momentum surge followed by a steep reversal, with repeated trading halts adding to the volatility. Traders are divided between bets on another short-squeeze rebound and warnings that the move is a pump-and-dump that could unwind further, with dilution also a concern.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealths quarterly earnings beat and raised profit outlook, supported by improved medical-cost management, are driving attention. Traders are split between viewing the results as evidence of a turnaround and questioning the medical-cost ratio and the muted, fading share-price reaction after an initial jump.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs third-quarter earnings beat, led by strong equities trading and investment-banking activity, is driving attention. Traders welcomed the results but debated the muted, fading share-price reaction after a prolonged decline, with some viewing the report as a turnaround signal and others frustrated that strong results have not translated into stronger performance.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

KTOSs prolonged selloff and repeated tests of new lows dominate discussion, with traders questioning why the shares remain weak despite reported contract wins, business updates, and analyst upgrades. Bears point to valuation concerns, insider selling, and pressure across defense stocks, while some investors view the decline as a buying opportunity based on the companys growth prospects.

Bumble, Inc. engages in the provision of online dating services. It operates through the following geographical segments: United States and Rest of the World. The company was founded by Whitney Wolfe Herd in 2014 and is headquartered in Austin, TX.

Bumble Inc - Ordinary Shares - Class A

Bumble Inc

Bumbles agreed all-cash take-private acquisition by Ithaca Holdings has driven the sharp share-price jump. Traders are celebrating gains and debating squeeze potential, while others say the offer price limits further upside and note that closing conditions remain.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson shares are falling sharply after quarterly results that modestly topped expectations, as traders focus on sluggish MedTech growth, the steep reported-earnings decline tied partly to one-time charges, and only a modest increase to full-year guidance. Some investors see the selloff as a buying opportunity, while others question whether the valuation is justified.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

A sharp selloff in AMAT and semiconductor equipment shares is driving discussion, with traders debating whether the drop marks capitulation and a buying opportunity or a continuing technical correction. Some point to broad chip-sector weakness and fund trimming, while others cite support levels and expect a rebound; no single company-specific cause is established in the conversation.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

The main discussion centers on Teladocs weaker outlook and the revenue pressure from shifting BetterHelp from cash-pay to insurance, with traders questioning whether provider-capacity constraints and management execution will delay a recovery. Bulls cite the insurance expansion, Teladoc One and AI strategy, and possible short-covering, while bears emphasize declining growth and lost confidence in leadership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$COSM this PR is just whats going to keep happening. More growth, more sales/deals, more  revenue. We havent heard what the other European expansion is bringing in and the weight loss pill could both be the next PRs. This seems to be why they reiterated 90m in revenue for the year so its going to be a blow out quarter. Kaboom!!!

jOEY

Joe Bananas

Jose

Josh Murray

StockTwits For Android 

Cosmos Health Inc. 

 this PR is just whats going to keep happening. More growth, more sales/deals, more  revenue. We havent heard what the other European expansion is bringing in and the weight loss pill could both be the next PRs. This seems to be why they reiterated 90m in revenue for the year so its going to be a blow out quarter. Kaboom!!!